Administration of venlafaxine after chronic methadone detoxification blocks post-depression relapse in rats

Administration of venlafaxine after chronic methadone detoxification blocks post-depression relapse in rats

Show other versions (1)

ABSTRACT Relapse is highly prevalent after detoxification and depression. Due to the advantages of venlafaxine compared with other antidepressants, it is expected that venlafaxine administration may reduce relapse after detoxification and depression. This study aimed to evaluate the effects of venla...

Full description

Bibliographic Details
Main Authors:	Meysam Fadaei-Kenarsary, Hadi Fathi Moghaddam, Seyyed Mohammad Taghi Mansouri, Yaghoob Farbood
Format:	Article
Language:	English
Published:	Instituto de Tecnologia do Paraná (Tecpar) 2017-08-01
Series:	Brazilian Archives of Biology and Technology
Subjects:	Morphine Methadone Depression Relapse Venlafaxine Rat
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132017000100311&tlng=en

Similar Items

Administration of venlafaxine after chronic methadone detoxification blocks post-depression relapse in rats
by: Meysam Fadaei-Kenarsary, et al.
Published: (2017-08-01)

Effects of Venlafaxine & Methadone Alone and in Combination with Spontaneous Morphine withdrawal Syndrome & Pain Sensation in Rats
by: Meisam Fadaei-kenarsary, et al.
Published: (2015-02-01)

Comparing the Effects of Methadone Administration with Sertraline or Venlafaxine on Depression, Anxiety, and Stress of Patients With Substance Abuse: A Clinical Trial
by: Mehdi Shomali Ahmadabad, et al.
Published: (2022-11-01)

Preventive Effect of Central Administration of Venlafaxine on Morphine Physical Dependence, Nociception, and Blood Cortisol Level in Rat
by: Majid Motaghinejad, et al.
Published: (2014-01-01)

Venlafaxine plus acceptance and commitment therapy enriched with compassion focus therapy in opioid-addicted patients undergoing methadone maintenance treatment: a clinical trial
by: Mohsen Zabihi, et al.
Published: (2023-03-01)

Dose of methadone and positive urinary morphine test in patients receiving methadone maintenance therapy (MMT)
by: Arash Mohagheghi, et al.
Published: (2022-06-01)

The anti-inflammatory effects of venlafaxine in the rat model of carrageenan-induced paw edema
by: Valiollah Hajhashemi, et al.
Published: (2015-07-01)

Postnatal development of rats exposed to fluoxetine or venlafaxine during the third week of pregnancy
by: V.A. da-Silva, et al.
Published: (1999-01-01)

Effectiveness of compassion-enriched acceptance and commitment therapy on depression, stress, and anxiety in opioid addicts receiving methadone maintenance compared to Venlafaxine combination therapy
by: Mehdi Shomaliahmadabadi, et al.
Published: (2022-10-01)

Environmental Enrichment Ameliorates Psychological Dependence Symptoms and Voluntary Morphine Consumption in Morphine Withdrawn Rats Under Methadone Maintenance Treatment
by: Marjan Lari, et al.
Published: (2021-09-01)

Personality Dimensions Influencing the Relapse of Substance Abuse in Drug Dependents under Methadone Maintenance Treatment
by: Akram Asgari, et al.
Published: (2011-11-01)

Venlafaxine Intoxication and Serotonin Syndrome
by: Mehmet Fatih Yörük, et al.
Published: (2018-10-01)

Effectiveness of Relapse Prevention Cognitive Behavioral Model in Opioid Dependent Patients Participating in the Methadone Maintenance Treatment in Iran
by: Fatemeh Rajati, et al.
Published: (2013-08-01)

Effectiveness of Relapse Prevention Cognitive-Behavioral Model in Opioid-Dependent Patients Participating in the Methadone Maintenance Treatment in Iran.
by: Tahereh Pashaei, et al.
Published: (2013-08-01)

Comparison of postoperative analgesia with methadone versus morphine in cardiac surgery
by: Ana Carolina Carvalho, et al.

Evaluation of the analgesic effect of subcutaneous methadone after cesarean section
by: Mitra Jabalameli, et al.
Published: (2014-01-01)

Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine
by: Florence Noble, et al.
Published: (2019-01-01)

Mitragynine Attenuates Morphine Withdrawal Effects in Rats—A Comparison With Methadone and Buprenorphine
by: Rahimah Hassan, et al.
Published: (2020-05-01)

Morphine Antinociception Restored by Use of Methadone in the Morphine-Resistant Inflammatory Pain State
by: Chizuko Watanabe, et al.
Published: (2020-12-01)

Venlafaxine-induced prostatism: a case report
by: Ibrahim Gundogmus, et al.
Published: (2017-04-01)

Is There a Potential of Misuse for Venlafaxine and Bupropion?
by: Fabrizio Schifano, et al.
Published: (2018-03-01)

Joint population pharmacokinetic modeling of venlafaxine and O-desmethyl venlafaxine in healthy volunteers and patients to evaluate the impact of morbidity and concomitant medication
by: Zhanzhang Wang, et al.
Published: (2022-12-01)

The Effect of Venlafaxine and Topiramate in Reducing Migraine Headaches in Patients with Abnormal Electroencephalogram
by: Fariborz Khorvash, et al.
Published: (2015-05-01)

Evaluation of morphine, methadone, digoxin, and dronabinol poisoning during the years 2017 to 2019 in Ilam, Iran
by: Kourosh Saki, et al.
Published: (2023-03-01)

Subarachnoidally administered hyperbaric morphine, buprenorphine, methadone, and 10% dextrose on cardiopulmonary function and behavior in horses
by: Cláudio Corrêa Natalini, et al.
Published: (2006-10-01)

Comparing Oprm1 Gene Promoter Methylation in the Lymphocytes of Male Rats Addicted to Nicotine, Morphine, Methadone, and Buprenorphine
by: Maedeh Mohammad Alizadeh, et al.
Published: (2019-11-01)

Comparative Analysis between Controlled Release Paroxetine and Extended-Release Venlafaxine for Treatment of Depression
by: Vijay Kaul, et al.
Published: (2022-06-01)

Persistant genital arousal disorder and venlafaxine: A case report
by: M. Marguilho, et al.
Published: (2021-04-01)

Facial Flushing Associated with Anxiety and Improved by Venlafaxine: A Case Report
by: Qiu Y, et al.
Published: (2022-09-01)

Venlafaxine‐induced interstitial lung disease with COVID‐19 pandemic‐related depression
by: Akihito Okazaki, et al.
Published: (2022-06-01)

Rapid, Precise and Affordable Estimation of Venlafaxine and Its Metabolites in Highly Polluted Effluent Waters: Proof-of-Concept for Methodology
by: Snawar Hussain, et al.
Published: (2020-10-01)

A Case of Ruminative Hypomania Induced by High Dose Venlafaxine
by: E. Yıldızhan, et al.
Published: (2022-06-01)

Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats
by: J.G. Santos Junior, et al.
Published: (2002-04-01)

A rare case with suicide due to akathisia after use of single dose venlafaxine
by: Nermin Gündüz, et al.
Published: (2018-06-01)

Neuroleptic Malignant Syndrome After the Use of Venlafaxine in a Patient with Generalized Anxiety Disorder
by: Tsung-Chien Lu, et al.
Published: (2006-01-01)

Lithium and venlafaxine poisoning — a case report
by: Sinkovič Andreja, et al.
Published: (2013-10-01)

Comparison of efficacy and tolerability of escitalopram and venlafaxine in treatment-naïve patients with unipolar nonpsychotic depression: Is there a need to revisit the prescription patterns?
by: Harneet Kaur, et al.
Published: (2019-01-01)

Comparisons of stress-related neuronal activation induced by restraint in adult male rat offspring with prenatal exposure to buprenorphine, methadone, or morphine
by: Chia-Yen Wu, et al.
Published: (2023-01-01)

Efficacy of methadone for the management of postoperative pain in laparoscopic cholecystectomy: A randomized clinical trial
by: Nicolás Arriaza, et al.
Published: (2021-03-01)

Recent Advances in the Electrochemical Sensing of Venlafaxine: An Antidepressant Drug and Environmental Contaminant
by: Somayeh Tajik, et al.
Published: (2020-06-01)